Efficiency of Biotech Firms in Taiwan and Mainland China: An Application of the Extended BCG Matrix
碩士 === 國立交通大學 === 管理學院碩士在職專班經營管理組 === 95 === This research applies the data envelopment analysis (DEA) to study ninety-four bio-pharmaceutical firms and twenty-four medical devices firms listed in the stock and OTC markets in Taiwan and mainland China from 2001 to 2005. The Boston Consulting Group...
Main Authors: | Hui-Ling Hsu, 許惠玲 |
---|---|
Other Authors: | Jin-Li Hu |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/84188192982338681838 |
Similar Items
-
Productivities of Biotech Firms in Mainland China and Taiwan
by: Tsou, Ming-Chao, et al.
Published: (2004) -
Technical, Efficiency and Sales Growth Rates of Biotech Firms in Taiwan
by: Pei-Ling Hsieh, et al.
Published: (2005) -
Market Entry Modeling for Biotech Pharmaceutical Firms to China
by: Finie Winata, et al.
Published: (2011) -
Investigation on Taiwan audit firm practices in Mainland China
by: Hui-ching Hsieh, et al.
Published: (2010) -
Cost Efficiency and Cost Malmquist Productivity Index for Biotech Firms in Taiwan
by: Meng-Kang Chung, et al.